Sphingosine-1-phosphate receptor: a novel therapeutic target in ulcerative colitis

Expert Rev Clin Immunol. 2016 Nov;12(11):1137-1139. doi: 10.1080/1744666X.2016.1217774. Epub 2016 Aug 8.
No abstract available

Keywords: S1P modulators; Sphingolipids; gut damage; inflammatory bowel disease; lymphocyte trafficking.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Colitis, Ulcerative / immunology
  • Colitis, Ulcerative / therapy*
  • Disease Models, Animal
  • Humans
  • Mesalamine / therapeutic use
  • Mice
  • Molecular Targeted Therapy
  • Receptors, Lysosphingolipid / immunology
  • Receptors, Lysosphingolipid / metabolism*
  • Signal Transduction
  • Steroids / therapeutic use
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Antibodies, Monoclonal
  • Receptors, Lysosphingolipid
  • Steroids
  • Tumor Necrosis Factor-alpha
  • Mesalamine